Table 1.
| Table 1A. PDEF expression in matched samples of benign breast and tumor tissues. | |||
| Benign/ Tumor pair number. | PDEF expression characteristics (Percent positive cells, intensity of staining). | ||
| Benign | Tumor | ||
| 1 | 0 | 40%, 1+ | |
| 2 | 0 | 20%, 2+ | |
| 3 | 40%, 2+ | 60%, 2+ | |
| 4 | 30%, 2+ | 5%, 1+ | |
| 5 | 5%, 1+ | 30%, 3+ | |
| 6 | 5%, 1+ | 20%, 2+ | |
| 7 | 0 | 80%, 2+ | |
| 8 | 15%, 1+ | 65%, 1+ | |
| 9 | 0 | 60%, 2+ | |
| Table 1B. PDEF expression in invasive ductal carcinoma in relation to other prognostic markers. | |||
| Marker Status | PDEF-positive | PDEF-negative | P-value |
| Her-2/neu-positive | 15 | 14 | 0.1478 |
| Her-2/neu-negative | 8 | 17 | |
| ER-positive | 24 | 26 | 0.2046 |
| ER-negative | 4 | 10 | |
| PR-positive | 18 | 21 | 0.7097 |
| PR-negative | 10 | 14 | |
| Tumor grades I and II | 17 | 20 | 0.6652 |
| Tumor grade III | 11 | 16 | |
| Lymph node-positive | 8 | 9 | 0.8371 |
| Lymph node-negative | 9 | 10 | |